Cargando…

Interleukin-6 levels in children developing SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Soraya, Gita Vita, Ulhaq, Zulvikar Syambani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198182/ https://www.ncbi.nlm.nih.gov/pubmed/32414693 http://dx.doi.org/10.1016/j.pedneo.2020.04.007

Ejemplares similares

Interleukin-6 as a potential biomarker of COVID-19 progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

An urgent call to identify the probable cause of severe acute hepatitis outbreak in children
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2022)

The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis
por: Soraya, Gita Vita, et al.
Publicado: (2020)

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis
por: Soraya, Gita Vita, et al.
Publicado: (2020)

The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2021)

Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2022)

Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2021)

A Roadmap for Future Parkinson's Pharmacogenomics in Asia
por: Akbar, Muhammad, et al.
Publicado: (2022)

The prevalence of anxiety symptoms and disorders among ophthalmic disease patients
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2022)

Brain Aromatase Modulates Serotonergic Neuron by Regulating Serotonin Levels in Zebrafish Embryos and Larvae
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2018)

The Association Between Genetic Polymorphisms in Estrogen Receptor Genes and the Risk of Ocular Disease: A Meta-Analysis
por: Ulhaq, Zulvikar Syambani
Publicado: (2020)

Brain aromatase modulates cardiac functions in embryonic zebrafish
por: Ulhaq, Zulvikar Syambani
Publicado: (2019)

Investigating the association of physical and psychological problems with the levels of interleukin-1 and -6 in COVID-19 patients
por: Bahadori-Birgani, Galia, et al.
Publicado: (2023)

Delayed versus immediate intervention of ruptured brain arteriovenous malformations: A case report
por: Bintang, Andi Kurnia, et al.
Publicado: (2023)

A Brief Analysis of Proteomic Profile Changes during Zebrafish Regeneration
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2021)

The effect of digital acupressure on chemotherapy-induced nausea in Indonesian patients with stages III-IV breast cancer
por: Wicaksono, Beni, et al.
Publicado: (2023)

Recurrent positive SARS-CoV-2 RNA tests in recovered and discharged patients()
por: Ulhaq, Z.S., et al.
Publicado: (2020)

Test ARN para SARS-CoV-2 positivos recurrentes en pacientes recuperados y dados de alta hospitalaria
por: Ulhaq, Z.S., et al.
Publicado: (2020)

Data on attitudes, religious perspectives, and practices towards COVID-19 among Indonesian residents: a quick online cross-sectional survey
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection
por: Ponziani, Francesca Romana, et al.
Publicado: (2021)

Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Majidpoor, Jamal, et al.
Publicado: (2022)

Interleukin-6 and Outcome of Chronic Hemodialysis Patients with SARS-CoV-2 Pneumonia
por: Donati, Gabriele, et al.
Publicado: (2022)

Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients
por: Li, Wangyang, et al.
Publicado: (2022)

Sequence analysis of SARS-CoV-2 Delta variant isolated from Makassar, South Sulawesi, Indonesia
por: Massi, Muhammad Nasrum, et al.
Publicado: (2023)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia
por: Masotti, Luca, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis
por: Diaz, Franco, et al.
Publicado: (2021)

SARS-CoV-2 infection in children
por: Çokuğraş, Haluk, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia
por: Massi, Muhammad Nasrum, et al.
Publicado: (2022)

Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
por: Zhang, Jing, et al.
Publicado: (2020)

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
por: Palanques-Pastor, Tomás, et al.
Publicado: (2020)

M090 Interleukine 6 is associated with severity and poor outcome in ICU-patients with SARS-CoV-2 infection
por: Mario, N., et al.
Publicado: (2022)

Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults
por: Bloise, Silvia, et al.
Publicado: (2021)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s13llr77qnj2lt1malnq8bjm78